AFB Drug susceptibility panel 1st and 2nd Line (10 drugs) by MGIT - Pure Culture
AFB Drug Susceptibility Panel - 1st and 2nd Line (10 drugs), Pure Culture Price
TB Drug Susceptibility Test Overview
The "AFB Drug susceptibility - 1st and 2nd Line (10 drugs) panel by MGIT - Pure Culture" test is a comprehensive and essential diagnostic tool for tuberculosis (TB) treatment. Using the MGIT (Mycobacteria Growth Indicator Tube) method on pure cultures of Mycobacterium tuberculosis (MTB) Complex, this test assesses the drug susceptibility of MTB to ten anti-tuberculosis drugs: Streptomycin, Isoniazid, Rifampicin, Ethambutol, Pyrazinamide, Kanamycin, Ethionamide, PAS (Para-AminoSalicylic Acid), Capreomycin, and Ofloxacin. The clinical utility of this test is vast as it provides critical information to healthcare professionals about the effectiveness of these drugs against the MTB Complex causing TB. By evaluating drug susceptibility to both first-line and second-line drugs, this test helps in the management of drug-sensitive and drug-resistant TB cases. The results enable clinicians to tailor personalized and effective treatment regimens, ensuring optimal care and increasing the chances of successful TB treatment. Overall, the AFB Drug susceptibility - 1st and 2nd Line (10 drugs) panel by MGIT is an indispensable tool in tuberculosis treatment, providing a comprehensive understanding of drug susceptibility patterns to guide targeted therapy. By enabling the selection of appropriate and effective drug combinations, this test significantly contributes to improved patient outcomes, better management of drug-resistant TB cases, and the overall fight against tuberculosis.
The AFB Drug Susceptibility Panel 1st and 2nd Line (10 drugs) by MGIT - Pure Culture is a comprehensive diagnostic test that evaluates the susceptibility of the Mycobacterium tuberculosis (MTB) complex to ten essential anti-tuberculosis drugs. This test utilises the Mycobacteria Growth Indicator Tube (MGIT) method on pure cultures of MTB, providing crucial insights into the effectiveness of various first-line and second-line drugs in treating tuberculosis. By assessing the susceptibility of MTB to drugs, this test enables doctors to develop personalised and effective treatment plans for patients with both drug-sensitive and drug-resistant tuberculosis.
The TB Drug Susceptibility Test plays a vital role in guiding the management of tuberculosis cases, as it helps identify the most appropriate drugs for each individual patient. By determining the susceptibility or resistance of the MTB strain to specific antibiotics, clinicians can tailor treatment regimens to maximise the chances of successful outcomes while minimising the risk of further drug resistance development.
Frequently asked questions
Find quick answers to the most common questions about health tests, bookings, and reports.
Regular exercise, a balanced diet, avoiding smoking, maintaining a healthy weight, and managing stress all help reduce heart disease risk.
Common signs include irritability, trouble sleeping, headaches, difficulty concentrating, and muscle tension.
Ratings & Reviews
We're satisfying our customers every day since 1980.
Choose precision On time, every time!
- 98% on time collections with a 60 minutes promise
- Real-time tracking of phlebotomist arrival and report generation
- Fully digital report delivery—view from mobile or desktop instantly
- Continuous monitoring of turnaround times to ensure accuracy and speed
- Dedicated support team to resolve any delays or queries quickly
Why Metropolis Healthcare?
Metropolis has been present for over 40 years in the market.
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
0
Years of experience
170+
Advanced Labs
Trusted by
Leading Doctors & Hospitals
2,000+
Scientific Officers
Proficiency Testing
for Accurate Reports
Latest Blogs & News
Stay informed with our expert insights and updates.
About Us
Metropolis Healthcare is a leading diagnostic service provider in India. We are a team of dedicated professionals committed to ensuring you and your family receive the most accurate and timely healthcare solutions. We believe in making health care accessible, affordable and evidence-based. Our expert panel are equipped with the latest technology and manned by a certified team of over 4000+ technicians.
In diagnostic services, we have more than three decades of experience servicing diverse stakeholders health advantage packages for men, women and seniors, genetic fitness & corporation in over 650+ tests like Oncology, Neurology, Gynaecology, Haematology, and many more. Our diagnostic services are located in leading doctors and clinics and serve over 15+ cities in India.